Literature DB >> 27317176

Generating Transgenic Mice by Lentiviral Transduction of Spermatozoa Followed by In Vitro Fertilization and Embryo Transfer.

Anil Chandrashekran1, Colin Casimir2, Nick Dibb3, Carol Readhead4, Robert Winston3.   

Abstract

Most transgenic technologies rely on the oocyte as a substrate for genetic modification. Transgenics animals are usually generated by the injection of the gene constructs (including lentiviruses encoding gene constructs or modified embryonic stem cells) into the pronucleus of a fertilized egg followed by the transfer of the injected embryos into the uterus of a foster mother. Male germ cells also have potential as templates for transgenic development. We have previously shown that mature sperm can be utilized as template for lentiviral transduction and as such used to generate transgenic mice efficiently with germ line capabilities. We provide here a detailed protocol that is relatively simple, to establish transgenic mice using lentivirally transduced spermatozoa. This protocol employs a well-established lentiviral gene delivery system (usual for somatic cells) delivering a variety of transgenes to be directly used with sperm, and the subsequent use of these modified sperm in in vitro fertilization studies and embryo transfer into foster female mice, for the establishment of transgenic mice.

Entities:  

Keywords:  Gene transfer; Germ line; Lentiviral vectors; Pseudotyping; Spermatozoa; Transgenes; Transgenics

Mesh:

Year:  2016        PMID: 27317176     DOI: 10.1007/978-1-4939-3753-0_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Detection of Indiscriminate Genetic Manipulation in Thoroughbred Racehorses by Targeted Resequencing for Gene-Doping Control.

Authors:  Teruaki Tozaki; Aoi Ohnuma; Kotono Nakamura; Kazuki Hano; Masaki Takasu; Yuji Takahashi; Norihisa Tamura; Fumio Sato; Kyo Shimizu; Mio Kikuchi; Taichiro Ishige; Hironaga Kakoi; Kei-Ichi Hirota; Natasha A Hamilton; Shun-Ichi Nagata
Journal:  Genes (Basel)       Date:  2022-09-04       Impact factor: 4.141

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.